Skip to main content

Table 1 Clinical Characteristics of Study Population

From: Expression signatures of TP53 mutations in serous ovarian cancers

 

Early Stage (n = 40)

Advanced Stage (n = 49)

Stage

Number (%)

Number (%)

IA

7 (17.5%)

 

IB

2 (5%)

 

IC

7 (17.5%)

 

IIA

1 (2.5%)

 

IIB

6 (15%)

 

IIC

17 (42.5%)

 

III

 

39 (79.6%)

IV

 

10 (20.4%)

Histological grade

  

Well differentiated

3 (7.5%)

2 (4.1%)

Moderately differentiated

9 (22.5%)

16 (32.6%)

Poorly differentiated

28 (70%)

31 (63.3%)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us